PHARMAGEN, INC. Retained Earnings
PHARMAGEN, INC. had Retained Earnings of -$9.86 million as of 2014-03-31, per its 10-Q filed 2014-05-15.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2014-05-15
- 2014-03-31: Retained Earnings (Accumulated Deficit) -$9.86M.
- 2013-12-31: Retained Earnings (Accumulated Deficit) -$9.15M.
- 2013-09-30: Retained Earnings (Accumulated Deficit) -$6.84M.
- 2013-06-30: Retained Earnings (Accumulated Deficit) -$5.49M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2014-03-31 | -$9.86M 10-Q · filed 2014-05-15 |
| 2013-12-31 | -$9.15M 10-Q · filed 2014-05-15 |
| 2013-09-30 | -$6.84M 10-Q · filed 2013-11-14 |
| 2013-06-30 | -$5.49M 10-Q · filed 2013-08-14 |
| 2013-03-31 | -$3.99M 10-Q · filed 2013-05-15 |
| 2012-12-31 | -$3.15M 10-K · filed 2014-03-31 |
| 2012-09-30 | -$2.23M 10-Q · filed 2012-11-14 |
| 2012-06-30 | -$1.19M 10-Q/A · filed 2012-09-14 |
| 2012-03-31 | -$719.91K 10-Q · filed 2012-06-11 |
| 2011-12-31 | -$376.62K 10-K · filed 2013-04-01 |